These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumour necrosis factor. Improving on the formula. Balkwill F Nature; 1993 Jan; 361(6409):206-7. PubMed ID: 8380903 [No Abstract] [Full Text] [Related]
3. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells. Katschinski DM; Robins HI; Schad M; Frede S; Fandrey J Cancer Res; 1999 Jul; 59(14):3404-10. PubMed ID: 10416602 [TBL] [Abstract][Full Text] [Related]
4. Expression and antitumor effects of TRAIL in human cholangiocarcinoma. Tanaka S; Sugimachi K; Shirabe K; Shimada M; Wands JR Hepatology; 2000 Sep; 32(3):523-7. PubMed ID: 10960444 [TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of the cDNA for canine tumor necrosis factor-alpha in E. coli. Zucker K; Lu P; Fuller L; Asthana D; Esquenazi V; Miller J Lymphokine Cytokine Res; 1994 Jun; 13(3):191-6. PubMed ID: 7948427 [TBL] [Abstract][Full Text] [Related]
6. Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in mice. Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K Anticancer Res; 1994; 14(6B):2573-6. PubMed ID: 7872683 [TBL] [Abstract][Full Text] [Related]
7. Two distinct tumour necrosis factor receptors--members of a new cytokine receptor gene family. Loetscher H; Brockhaus M; Dembic Z; Gentz R; Gubler U; Hohmann HP; Lahm HW; Van Loon AP; Pan YC; Schlaeger EJ Oxf Surv Eukaryot Genes; 1991; 7():119-42. PubMed ID: 1661597 [No Abstract] [Full Text] [Related]
9. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression. Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577 [TBL] [Abstract][Full Text] [Related]
10. Cloning and expression in murine erythroleukemia cells: the soluble forms of the type I and type II tumor necrosis factor receptors fused to an immunogenic affinity tag. Newton CR; MacCallum LJ; McPheat W; Carr H; Foster HR; Abbott WM; Needham M; Dinsmore A; Copley CG Protein Expr Purif; 1994 Oct; 5(5):449-57. PubMed ID: 7530072 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells. Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329 [TBL] [Abstract][Full Text] [Related]
13. [Comparative study of the effect of recombinant tumor necrosis factor and synthetic peptides, corresponding to its fragments, on phagocytosis,mediated by Fc- and MF-receptors]. Koniaev IG; Freĭdlin IS; Maĭrov VA; Zav'ialov VP Biull Eksp Biol Med; 1996 Mar; 121(3):304-8. PubMed ID: 8688535 [No Abstract] [Full Text] [Related]
14. Molecular, biochemical, and functional characteristics of tumor necrosis factor-alpha produced by human placental cytotrophoblastic cells. Yang Y; Yelavarthi KK; Chen HL; Pace JL; Terranova PF; Hunt JS J Immunol; 1993 Jun; 150(12):5614-24. PubMed ID: 8390539 [TBL] [Abstract][Full Text] [Related]
16. [Tumor necrosis factor. From theory to practice]. Boudes P; Guillevin L Ann Med Interne (Paris); 1989; 140(8):715-20. PubMed ID: 2698074 [No Abstract] [Full Text] [Related]